Jonathan M. Hernandez

National Institutes of Health — United States

Medicine · Health Sciences

37h-index12.4kcitations460works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(52), Cancer, Hypoxia, and Metabolism(52), Helicobacter pylori-related gastroenterology studies(41), Gastric Cancer Management and Outcomes(39), Ubiquitin and proteasome pathways(37)

Publications459 total

Single-cell spatial proteomics maps human liver zonation patterns and their vulnerability to disruption in tissue architecture
Nature Metabolism·2026· 1 citedOpen Access
ASO Visual Abstract: Efficacy of Bidirectional Paclitaxel Plus Capecitabine or Nilotinib for Peritoneal Carcinomatosis: A Single-Institution Analysis of Two Phase II Clinical Trials
Annals of Surgical Oncology·2026
Surgery for Gastroenteropancreatic Neuroendocrine Tumors with Synchronous Liver Metastasis
Annals of Surgical Oncology·2026
The IBEX knowledge-base a community resource enabling adoption and development of immunofluorescence imaging methods
eLife·2026Open Access
The IBEX Knowledge-Base: A Community Resource Enabling Adoption and Development of Immunofluorescence Imaging Methods
2026Open Access
Longitudinal human transcriptomic and spatial gene profiling at the incisional edge during long surgical procedures
Communications Biology·2025· 1 citedOpen Access
Clinical and Genetic Insights into Partial RAG Deficiency in Adults: When to Consider Hematopoietic Stem Cell Transplantation?
Journal of Human Immunity·2025Open Access
Hepatic lymph node metastases in patients with colorectal liver metastases undergoing hepatic artery infusion pump placement
Annals of Hepato-Biliary-Pancreatic Surgery·2025Open Access
Figure S12 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Figure S10 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Table S2 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Figure S1 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Figure S13 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Data from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Figure S6 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Figure S5 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Figure S8 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Figure S4 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Figure S7 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Figure S15 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
page 1 of 23Next →

Frequent Co-authors

Jeremy L. Davis(16), Alexander S. Rosemurgy(12), Sharona Ross(11), Connor Morton(8), Linda Bojmar(6), David Shibata(6), Desireé Villadolid(6), Samantha M. Ruff(6), Haiying Zhang(5), William R. Jarnagin(5), David Lyden(5), Sean P. Martin(5), Tim F. Greten(5), W. Edwin Clark(5), Reed I. Ayabe(5), Michael M. Wach(5), Laurence P. Diggs(5), Ayuko Hoshino(4), John H. Healey(4), Vinagolu K. Rajasekhar(4)